Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Virpax Pharmaceuticals is a preclinical-stage biotech focused on developing proprietary drug delivery systems for pain management and CNS disorders. Its technologies include intranasal and liposomal formulations targeting opioid-free pain relief, PTSD, epilepsy, and viral protection. The company partners with third parties for manufacturing and clinical trials, and seeks regulatory approval for innovative treatments, aiming to improve patient quality of life through non-addictive, targeted therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.